NYSEARCA:FSZ

First Trust Switzerland AlphaDEX Fund Stock Forecast, Price & News

$68.89
-1.09 (-1.56 %)
(As of 09/17/2021 12:00 AM ET)
Add
Today's Range
$68.74
$69.65
50-Day Range
$66.43
$71.20
52-Week Range
$51.04
$71.60
Volume2,142 shs
Average Volume5,305 shs
Market Capitalization$110.22 million
P/E RatioN/A
Dividend Yield1.06%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive FSZ News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust Switzerland AlphaDEX Fund and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer First Trust
Fund NameFirst Trust Switzerland AlphaDEX Fund
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:FSZ
Inception Date2/14/2012
Fund ManagerDaniel J. Lindquist, Jon C. Erickson, David G. McGarel, Roger F. Testin, Stan Ueland, Chris A. Peterson
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNASDAQ AlphaDEX Switzerland Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionEurope

Fund Statistics

Assets Under Management$110.21 million
Average Daily Volume$7,624.80
Discount/Premium0.01%

ETF Expenses

Management Fee0.80%
Other Expenses0.00%
Total Expenses0.80%
Fee Waiver0.00%
Net Expenses0.80%

Administrator, Advisor and Custodian

AdministratorBrown Brothers Harriman & Co.
AdvisorFirst Trust Advisors L.P.
CustodianBrown Brothers Harriman & Co.
DistributorFirst Trust Portfolios L.P.
Transfer AgentBrown Brothers Harriman & Co.
Trustee
Lead Market MakerCredit Suisse

Geographic Exposure of FSZ

Currency Exposure of FSZ

Sector Exposure of FSZ

Industry Exposure of FSZ

speech bubbles
speech bubbles











First Trust Switzerland AlphaDEX Fund (NYSEARCA:FSZ) Frequently Asked Questions

What stocks does MarketBeat like better than First Trust Switzerland AlphaDEX Fund?

Wall Street analysts have given First Trust Switzerland AlphaDEX Fund a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but First Trust Switzerland AlphaDEX Fund wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has First Trust Switzerland AlphaDEX Fund's stock been impacted by Coronavirus?

First Trust Switzerland AlphaDEX Fund's stock was trading at $45.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, FSZ stock has increased by 52.0% and is now trading at $68.89.
View which stocks have been most impacted by COVID-19
.

Is First Trust Switzerland AlphaDEX Fund a good dividend stock?

First Trust Switzerland AlphaDEX Fund pays an annual dividend of $0.74 per share and currently has a dividend yield of 1.06%.
View First Trust Switzerland AlphaDEX Fund's dividend history.

What is First Trust Switzerland AlphaDEX Fund's stock symbol?

First Trust Switzerland AlphaDEX Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "FSZ."

How do I buy shares of First Trust Switzerland AlphaDEX Fund?

Shares of FSZ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is First Trust Switzerland AlphaDEX Fund's stock price today?

One share of FSZ stock can currently be purchased for approximately $68.89.

How much money does First Trust Switzerland AlphaDEX Fund make?

First Trust Switzerland AlphaDEX Fund has a market capitalization of $110.22 million.


This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.